Picture of Takara Bio logo

4974 — Takara Bio News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareBalancedMid CapNeutral

Table: Takara Bio -Q1 group results

Aug 8 (Reuters)- 
             Takara Bio Inc. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2023        Jun 30, 2022     Mar 31, 2024 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             9.18                14.10            53.30    
                 (-34.9 pct)         (-7.7 pct)       (-31.8 pct) 
  Operating        423 mln               4.54             8.00    
                 (-90.7 pct)         (-46.6 pct)      (-61.1 pct) 
  Recurring        509 mln               4.59             8.20    
                 (-88.9 pct)         (-46.5 pct)      (-60.4 pct) 
  Net              319 mln               3.91             5.50    
                 (-91.8 pct)         (-35.1 pct)      (-65.7 pct) 
  EPS             2.65 yen            32.45 yen        45.67 yen  
  Ann Div                             42.00 yen        17.00 yen  
  -Q2 div                                NIL              NIL     
  -Q4 div                             42.00 yen        17.00 yen  
  
  NOTE - Takara Bio Inc.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T

Recent news on Takara Bio

See all news